Recently recognized by the World Health Organization, acute myeloid leukemia (AML) with t(7;12)(q36;p13) has previously been associated with MNX1 and ETV6 signaling, although MNX1::ETV6 fusion ...
The findings from Dana-Farber researcher to be presented at the 66th American Society of Hematology (ASH) Annual Meeting & Exposition SAN DIEGO - Dana-Farber Cancer Institute researchers are leading ...
Hosted on MSN
What To Know About Acute Myelogenous Leukemia (AML)
Acute myelogenous leukemia (AML), also known as acute myeloid leukemia, is a type of cancer that starts in your bone marrow (the soft, spongy tissue inside the bones that makes blood cells). AML is ...
1d
Blood Cancer United Expands its Beat AML® Master Clinical Trial Advancing Next-Generation Treatment
Blood Cancer United®, formerly The Leukemia & Lymphoma Society, announced today that the first patient has received treatment ...
A highly sensitive bone marrow test could double survival rates for some groups of younger adults with Acute Myeloid Leukemia (AML) by helping doctors identify if they might relapse up to three months ...
Allo-HSCT significantly improved survival in real-world pediatric AML, with CR1 patients showing the best outcomes, achieving OS and DFS rates of 84.2% and 73.4%. Matched sibling and unrelated donors ...
COLUMBUS, Ohio – Researchers at The Ohio State University Comprehensive Cancer Center – Arthur G. James Cancer Hospital and Richard J. Solove Research Institute (OSUCCC – James) led a global study ...
Acute myeloid leukemia (AML) is a cancer of the blood-cell producing bone marrow with several subtypes, and is usually fatal within months, or even weeks, if left untreated. It is now becoming clear, ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback